Lidds Ab (publ)Company Review & Valuation

LIDDS
Nasdaq First North Growth Market
Latest Price
12.24SEK
Market Capitalization
296.88mSEK

About Lidds Ab (publ)

LIDDS AB (publ) develops and sells pharmaceutical products for cancer and other diseases worldwide. It is developing various drugs, such as NZ-2HOF to treat prostate cancer; NZ-DTX for lung cancer and solid tumors; NZ-DOX for solid tumors; NZ-IO, an antibody-based immunotherapy; NZ-STING for immuno-Show more oncology; and NZ-BELINA for breast cancer. The company is based in Uppsala, Sweden. Show less

Industry
Biotechnology
HQ Location
Uppsala, Sweden

Stock Price

Price data not available for Lidds Ab (publ).

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

back to top